13F Holdings
中文EN

LFWD Lifeward Ltd.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 1607962 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-14.1%
TTM net income YoY-9.6%
TTM EPS YoY74.7%
Revenue 3-yr CAGR32.0%
Net income 3-yr CAGR—

Margins

Gross margin31.5%
Operating margin-121.5%
Net margin-155.4%
FCF margin-93.3%
EBITDA margin-120.2%

Returns

ROE-326.8%
ROA-121.9%
ROIC (approx.)-308.2%
Asset turnover0.78x

Leverage & solvency

Liabilities / assets76.2%
Debt / equity0.00x
Current ratio2.00x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.60x
Accruals ratio-48.8%
Payout ratio—
Capex / revenue0.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$22.03M$25.66M$13.85M$5.51M$5.97M
Cost of revenue$13.61M$17.45M$9.40M$3.61M$3.06M
Gross profit$8.43M$8.22M$4.45M$1.91M$2.90M
R&D expense$3.25M$4.62M$4.15M$4.03M$2.94M
SG&A expense$8.20M$5.20M$9.99M$7.13M$5.63M
Operating income-$19.67M-$29.35M-$23.61M-$19.10M-$12.65M
Interest expense————$0
Pretax income-$19.97M-$28.90M-$22.14M-$19.10M-$12.64M
Income tax-$55,000$43,000-$12,000$467,000$94,000
Net income-$19.91M-$28.94M-$22.13M-$19.57M-$12.74M
EBITDA-$19.34M-$28.85M-$23.37M-$18.90M-$12.39M
EPS (basic)-17.16-39.96-31.13-2.20-0.27
EPS (diluted)-17.16-39.96-31.13-2.20-0.27
Weighted avg. shares (diluted)1.16M724,272710,9418.91M47.94M
Banking
Net interest income-$312,000$643,000$1.35M$0$0
Balance sheet
Cash & equivalents$2.17M$7.11M$28.79M$68.56M$89.05M
Receivables$6.14M$6.00M$3.12M$1.04M$585,000
Inventory$5.73M$6.72M$5.65M$2.93M$2.99M
Current assets$15.81M$21.29M$39.22M$72.51M$92.52M
PP&E, net$585,000$867,000$1.26M$196,000$284,000
Goodwill$4.75M$7.54M$7.54M$0—
Intangibles—$0$12.53M——
Total assets$22.90M$30.49M$63.19M$74.24M$94.75M
Current liabilities$12.04M$10.22M$11.79M$4.78M$4.04M
Total liabilities$14.49M$11.64M$16.68M$6.07M$5.37M
Shareholders' equity$8.41M$18.85M$46.51M$68.17M$89.38M
Shares outstanding1.52M733,9668.59M60.09M62.48M
Cash flow statement
Operating cash flow-$16.83M-$21.72M-$20.67M-$17.89M-$11.47M
Capital expenditure$16,000$0$81,000$25,000$47,000
Free cash flow-$16.84M-$21.72M-$20.75M-$17.92M-$11.52M
Investing cash flow-$16,000$0-$18.15M-$25,000-$47,000
Financing cash flow$12.20M$0-$992,000-$2.50M$79.51M
Depreciation & amortization$333,000$494,000$239,000$202,000$266,000
Stock-based compensation$743,000$1.28M$1.33M$993,000$833,000

Free plan shows the latest 5 periods; Pro shows all 14 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.